Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Tiziana Life Sciences Announces FDA Allowance For Additional Patients To Be Enrolled In Intranasal Foralumab Multiple Sclerosis Expanded Access Program

Author: Benzinga Newsdesk | April 23, 2024 07:41am

Program to expand from 10 patients to a total of 30 patients.

Posted In: TLSA